Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
46 /100
MEDIUM RISK
Score updated Oct 27, 2026

GLSI — Greenwich LifeSciences, Inc. Dilution Risk Tracker

Track GLSI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GLSI — Get alerts when the score changes →

As of October 27, 2026, Greenwich LifeSciences, Inc. (GLSI) has a DilutionWatch DilutionScore of 46/100, rated MEDIUM dilution risk. Greenwich LifeSciences, Inc. has a market capitalization of $253.35M, 14.68M shares outstanding, 64 institutional holders tracked. Stored dilution-related fields include 20.2K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
65
📊 Float Risk
55
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
💰 Capital Raise model 15%
• Under 12 months cash (8mo)
🔔 Track GLSI — Get forecast alerts →

Market Data

Market Cap$253.35M
Shares Outstanding14.68M
Float6.57M
Cash$6.18M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore46/100DilutionWatch score record
Shares Outstanding14.68MVerified float table or market cache
Public Float6.57MVerified float table or market cache
Market Cap$253.35MMarket data cache
Cash Runway7.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants20.2KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

GLSI SEC Filing Activity — Last 12 Months

Shares outstanding reported by GLSI on the cover page of its latest 10-K/10-Q: 14.68M as of July 24, 2026.

DilutionWatch recorded no shelf, registration or prospectus documents for GLSI in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
DEF 14Aproxy statement1Oct 26, 2026
4insider transaction3Jul 30, 2026

Institutional Holdings

QoQ: ↑ 57.5% shares (2026Q1 vs prior)
64 institutional holders · 2.11M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 596.5K shares
#2 BlackRock, Inc. 433.9K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 155.5K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.55M
Days to Cover10.7
% of Float23.6%
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-01
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual GLSI Dilution Snapshot

Greenwich LifeSciences, Inc. (GLSI) has a DilutionScore of 46/100, rated Medium dilution risk. Score date: October 27, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

GLSI's DilutionScore is currently 46/100 (Medium risk), with 3 score changes tracked over 89 days. The score deteriorated from 60/100 (High risk).

Period Score Risk Level Duration
Sep 30 – Oct 27, 202646/100MEDIUM28 days
Aug 22 – Sep 29, 202660/100HIGH39 days
Aug 14 – Aug 21, 202650/100MEDIUM7 days
Jul 30 – Aug 13, 202660/100HIGH15 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track GLSI Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment GLSI files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking GLSI — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,566+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for GLSI
GLSI FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.